CITIGROUP INC - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$107
-99.8%
99
-99.8%
0.00%
Q2 2023$65,763
-59.8%
50,979
-58.9%
0.00%
Q1 2023$163,760
+369.5%
124,061
+433.5%
0.00%
Q4 2022$34,882
-12.8%
23,254
-32.0%
0.00%
Q3 2022$40,000
-97.7%
34,216
-97.8%
0.00%
-100.0%
Q2 2022$1,777,000
+197.7%
1,573,021
+688.7%
0.00%
Q1 2022$597,000
-45.1%
199,439
-51.4%
0.00%
-100.0%
Q4 2021$1,088,000
+39.7%
410,496
+91.2%
0.00%
Q3 2021$779,000
-71.9%
214,651
-66.4%
0.00%
-100.0%
Q2 2021$2,774,000
+4.6%
639,213
-17.5%
0.00%0.0%
Q1 2021$2,651,000
+241.6%
775,040
+249.5%
0.00%
Q4 2020$776,000
+882.3%
221,745
+570.7%
0.00%
Q3 2020$79,000
-38.8%
33,064
-53.0%
0.00%
Q2 2020$129,000
-8.5%
70,328
-22.2%
0.00%
Q1 2020$141,000
+8.5%
90,372
+49.4%
0.00%
Q4 2019$130,000
-65.6%
60,476
-70.1%
0.00%
Q3 2019$378,000
-30.4%
202,118
-2.9%
0.00%
Q2 2019$543,000
+4.8%
208,107
+3.3%
0.00%
Q1 2019$518,000
-71.8%
201,534
-74.8%
0.00%
-100.0%
Q4 2018$1,836,000
-17.9%
798,741
+14.7%
0.00%0.0%
Q3 2018$2,236,000
-14.6%
696,534
-24.7%
0.00%0.0%
Q2 2018$2,618,000
-26.2%
925,517
-7.6%
0.00%
-33.3%
Q1 2018$3,546,000
+393.9%
1,001,528
+441.4%
0.00%
+200.0%
Q4 2017$718,000
+2891.7%
184,998
+1765.7%
0.00%
Q3 2017$24,000
-31.4%
9,916
-22.7%
0.00%
Q2 2017$35,000
-59.3%
12,828
-49.8%
0.00%
Q1 2017$86,000
-89.4%
25,563
-92.5%
0.00%
-100.0%
Q4 2016$812,000
+83.3%
341,692
+182.8%
0.00%
Q3 2016$443,000
+884.4%
120,805
+493.4%
0.00%
Q2 2016$45,000
-74.1%
20,357
-75.7%
0.00%
Q1 2016$174,000
+48.7%
83,932
+117.1%
0.00%
Q4 2015$117,00038,656
+32113.3%
0.00%
Q3 2015$0
-100.0%
120
-92.5%
0.00%
Q2 2015$5,000
-73.7%
1,603
-71.2%
0.00%
Q1 2015$19,000
-52.5%
5,559
-68.3%
0.00%
Q4 2014$40,000
+566.7%
17,518
+475.9%
0.00%
Q3 2014$6,000
-83.8%
3,042
-69.9%
0.00%
Q2 2014$37,000
-59.8%
10,120
-57.5%
0.00%
Q1 2014$92,000
-27.6%
23,833
-46.2%
0.00%
Q4 2013$127,000
-2.3%
44,259
+21.0%
0.00%
Q3 2013$130,000
-7.1%
36,574
-13.0%
0.00%
Q2 2013$140,00042,0410.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders